- Home
- DLNG vs INO Comparison
DLNG vs INO Comparison
Compare DLNG & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLNG
- INO
- Stock Information
- Founded
- DLNG 2013
- INO 1979
- Country
- DLNG Greece
- INO United States
- Employees
- DLNG N/A
- INO N/A
- Industry
- DLNG Marine Transportation
- INO Medical/Dental Instruments
- Sector
- DLNG Consumer Discretionary
- INO Health Care
- Exchange
- DLNG Nasdaq
- INO Nasdaq
- Market Cap
- DLNG 131.9M
- INO 128.1M
- IPO Year
- DLNG 2013
- INO 1998
- Fundamental
- Price
- DLNG N/A
- INO $2.56
- Analyst Decision
- DLNG
- INO Buy
- Analyst Count
- DLNG 0
- INO 5
- Target Price
- DLNG N/A
- INO $8.80
- AVG Volume (30 Days)
- DLNG 42.9K
- INO 1.1M
- Earning Date
- DLNG 11-21-2025
- INO 11-13-2025
- Dividend Yield
- DLNG 5.57%
- INO N/A
- EPS Growth
- DLNG 90.14
- INO N/A
- EPS
- DLNG 1.14
- INO N/A
- Revenue
- DLNG $158,453,000.00
- INO $182,337.00
- Revenue This Year
- DLNG N/A
- INO N/A
- Revenue Next Year
- DLNG $0.37
- INO $15,960.33
- P/E Ratio
- DLNG $3.04
- INO N/A
- Revenue Growth
- DLNG N/A
- INO N/A
- 52 Week Low
- DLNG $3.18
- INO $1.30
- 52 Week High
- DLNG $5.65
- INO $5.83
- Technical
- Relative Strength Index (RSI)
- DLNG N/A
- INO 53.44
- Support Level
- DLNG N/A
- INO $2.28
- Resistance Level
- DLNG N/A
- INO $2.58
- Average True Range (ATR)
- DLNG 0.00
- INO 0.13
- MACD
- DLNG 0.00
- INO -0.03
- Stochastic Oscillator
- DLNG 0.00
- INO 38.10
About DLNG Dynagas LNG Partners LP Common Units
Dynagas LNG Partners LP is a limited partnership company focused on owning and operating high specification and versatile LNG carriers that are employed on multi-year contracts with international energy companies, providing the benefits of stable cash flows and high utilization rates. The company defines charters of two years or more as multi-year charters. Its current LNG Carrier fleet is optimized for trading flexibility. In addition to conventional trade, part of LNG Carrier fleet is assigned with Ice Class 1A FS notation and are winterized which enables trade in subzero and ice bound conditions.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.